Dow Down 0.79% Nasdaq Down 0.81%

Celldex Therapeutics, Inc. (CLDX)

-NasdaqGS
12.47 Down 0.49(3.78%) 11:02AM EDT - Nasdaq Real Time Price
Prev Close:12.96
Open:12.88
Bid:12.47 x 300
Ask:12.49 x 300
1y Target Est:33.63
Beta:3.32
Earnings Date:Nov 6 - Nov 10 (Est.)
Day's Range:12.25 - 12.99
52wk Range:10.76 - 38.84
Volume:999,181
Avg Vol (3m):1,912,130
Market Cap:1.11B
P/E (ttm):N/A
EPS (ttm):-1.21
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CLDX

Comparison

Symbol% ChgMkt Cap
CLDXDown 3.78%1.11B
DNDNDown 5.55%211.40M
LLYUp 0.57%69.90B
RHHBYDown 0.28%250.65B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):444.27
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.32
Quarterly EPS Est (Sep-14) :-0.33
Mean Recommendation*:1.3
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Celldex Therapeutics, Inc., a biopharmaceutical company, focuses on the development, manufacture, and commercialization of novel therapeutics for human health care primarily in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback